A Prospective Study of Medical Therapy Against Cryoballoon Ablation in Symptomatic Recent Onset Persistent AF
Status:
Unknown status
Trial end date:
2020-03-01
Target enrollment:
Participant gender:
Summary
Prospective trial comparing the efficacy and safety of CryoBalloonAblation (CBA) to
standardized medication for treatment of early onset persistent atrial fibrillation (AF)
without structural heart disease. The value of CBA in these patients has never been studied;
the endpoints for persistent patients are much easier than for paroxysmal patients. Reduction
in left atrial (LA) size will be compared versus patients on drug therapy and versus failing
patients.